Susquehanna International Group, LLP Foghorn Therapeutics Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 15,798 shares of FHTX stock, worth $94,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,798
Previous 39,591
60.1%
Holding current value
$94,156
Previous $368,000
79.89%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding FHTX
# of Institutions
85Shares Held
36.3MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$75.5 Million17.9% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$31.6 Million0.94% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$19.4 Million0.38% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$13.7 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.03MShares$12.1 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $248M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...